Page last updated: 2024-12-07
pantoyltaurine
Description
Pantoyltaurine is a synthetic derivative of pantothenic acid (vitamin B5) and taurine. It is thought to act as a neurotransmitter and may play a role in brain function. Research suggests that pantoyltaurine may have potential benefits in treating conditions such as Alzheimer's disease and Parkinson's disease. Its synthesis involves the reaction of pantothenic acid with taurine. The compound is studied for its potential to protect against nerve cell damage and to improve cognitive function. However, more research is needed to fully understand the mechanisms of action and potential therapeutic benefits of pantoyltaurine.'
pantoyltaurine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 95350 |
SCHEMBL ID | 6673173 |
MeSH ID | M0043971 |
Synonyms (17)
Synonym |
pantoylaurine |
thiopanic acid |
taurine,4-dihydroxy-3,3-dimethylbutyryl)- |
ethanesulfonic acid,4-dihydroxy-3,3-dimethyl-1-oxobutyl)amino]-, (r)- |
nsc-3086 |
x 184 |
nsc3086 |
pantoyltaurine |
pantoyl taurine |
2545-84-8 |
sulfopantothenic acid |
ethanesulfonic acid, 2-[(2,4-dihydroxy-3,3-dimethyl-1-oxobutyl)amino]-, (r)- |
nsc122022 |
2-((2,4-dihydroxy-3,3-dimethylbutanoyl)amino)ethanesulfonic acid |
2-[(2,4-dihydroxy-3,3-dimethyl-butanoyl)amino]ethanesulfonic acid |
2-[(2,4-dihydroxy-3,3-dimethylbutanoyl)amino]ethanesulfonic acid |
SCHEMBL6673173 |
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.15
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.15 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 4.45 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |